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Introduction: The purpose of this study was to investigate the expression of Wnt and Notch signaling pathway-related
genes in inflammatory bowel disease (IBD) treated with mesenchymal stem cell transplantation (MSCT).
Methods: TNBS (2,4,6-trinitrobenzene sulfonic acid) was used to establish IBD in a rat model. Mesenchymal stem cells
(MSCs) were transplanted via tail vein transfusion. Saline water was used in a control group. The expression of Wnt and
Notch main signaling molecules was screened by gene chips and verified by quantitative reverse transcription-polymerase
chain reaction in the IBD rat model on day 14 and day 28 after transplantation.
Results: The IBD rat models were successfully established and MSCs were transplanted into those models. Genome-wide
expression profile chips identified a total of 388 differentially expressive genes, of which 191 were upregulated and 197
were downregulated in the MSC-transplanted group in comparison with the IBD control group. Real-time quantitative
polymerase chain reaction results showed that the level of Olfm4 mRNA expression in the IBD group (2.54±0.20) was
significantly increased compared with the MSCT group (1.39±0.54) and the normal group (1.62±0.25) (P <0.05). The Wnt3a
mRNA was more highly expressed in IBD rats (2.92±0.94) and decreased in MSCT rats (0.17±0.63, P <0.05). The expression
of GSK-3β mRNA was decreased in the setting of inflammation (0.65±0.04 versus 1.00±0.01 in normal group, P <0.05) but
returned to normal levels after MSCT (0.81±0.17). The expression of β-catenin was observed to increase in IBD tissues
(1.76±0.44) compared with normal tissues (1.00±0.01, P <0.05), but no difference was found in the MSCT group (1.12±0.36).
Wnt11 declined at 14 days and returned to normal levels at 28 days in the IBD group; in comparison, a significantly lower
expression was found in MSCT rats. There were no differences in the expression of Fzd3, c-myc, TCF4, and Wnt5a in
inflammation, but all of those genes declined after MSCT treatment.
Conclusions: The canonical Wnt and Notch signaling pathways are activated in IBD and may be suppressed by stem cell
transplantation to differentiate into intestinal epithelium after MSCT. Moreover, the non-canonical Wnt signaling may be
inhibited by canonical Wnt signaling in the setting of inflammation and may also be suppressed by MSCT.Introduction
Inflammatory bowel disease (IBD) includes ulcerative colitis
(UC) and Crohn’s disease (CD). These conditions produce
recurrent chronic inflammatory illnesses of the intestinal* Correspondence: weiyaming@163.com
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creativecommons.org/publicdomain/zero/1.0/tract. Studies show that IBD comprises heterogeneous dis-
orders of various etiologies, in which hereditary predis-
position, environmental factors, and abnormal immune
response work together to induce this disease [1, 2]. Cur-
rently, the conventional medications are salicylic acid, corti-
costeroids, immunosuppressive agents, and antibiotics [3].
Although these therapies may offer temporary remission,
curative effect is not very obvious, and adverse reactions [4]
such as psoriasis [5], drug-induced cytotoxicity [6], and
hypersensitivity [7] may arise in response to treatment.le distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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ferentiation, and engraftment capacity in appropriate target
tissues [8]. Several studies have reported the MSCT in the
treatment of UC and CD could restore epithelial barrier
integrity[8], induce immune suppression [9, 10], and stimu-
late regeneration of endogenous host progenitor cells [11].
In a previous study, we confirmed by in situ hybridazation
and immunohistochemistry that allogenic transplanted
hematopoietic stem cells or MSCs could populate the in-
jured regions of the colon [12]. MSCs not only stimulated
progenitor cells to improve epithelial renewal but also
engrafted in the damage tissues and even differentiated into
colonic interstitial cells [13]. However, the mechanisms are
not clear. In particular, we do not know which genes and
pathways are involved in reparation of the mucosa and
transformation into intestinal epithelial cells.
The Wnt signaling pathway and Notch signaling path-
way are major pathways in stem cell proliferation and dif-
ferentiation capacity. Wnt signaling is classified as two
types: canonical pathway and non-canonical pathway [14].
Wingless-type mouse mammary tumor virus (MMTV) in-
tegration site family, member 3A (Wnt3a) activates the
canonical Wnt signaling pathway, which is a prominent
member of the Wnt family. The other members of
the Wnt ligand family—such as Wingless-type MMTV
integration site family, member 5A (Wnt5a) and
Wingless-type MMTV integration site family, member
11 (Wnt11)—activate the non-canonical Wnt signaling
pathway [15]. The Notch signaling pathway can be acti-
vated by inhibiting atonal homolog 1 (Atoh1) gene ex-
pression, which determines cell fate [16]. The Wnt
signaling pathway can promote progenitor cell prolifera-
tion, maintain a cycling cell type, and prevent differenti-
ation. Meanwhile, the Notch pathway has the capacity
to maintain the progenitor cells in an undifferentiated,
proliferating state [17]. Wnt and Notch pathways are
very important in the regulation of cell fate. These path-
ways have been widely investigated in normal tissues
but not in inflammatory colonic tissues or in the setting
of colonic tissue regeneration secondary to MSCT.
In this study, we explored the differential expression of
genes associated with the Wnt and Notch signaling path-
ways in MSCT of an IBD rat model. Using a cDNA chip,
we verified these related genes by quantitative reverse
transcription-polymerase chain reaction (RT-PCR). We
will discuss the mechanism of differentiation of implanted
MSCs in the repair of damaged intestinal epithelium.Methods
Animals
Eighteen Sprague Dawley male rats weighing 180 to 200 g
were maintained in accordance with the guidelines of the
Committee for Animal Research of Guangzhou MedicalUniversity. This study was conducted in accordance with
the Regulations for the Administration of Affairs Concern-
ing Experimental Animals. All animal experiments were
approved by the Guangdong Medical Laboratory Animal
Center. Eighteen male rats were randomly divided into
three groups, and each group included six rats. There are
three groups: normal control group, IBD group, and MSC
transplantation group (MSCT group).
Cells
MSCs, which were labeled with green fluorescent protein
(GFP), were obtained from Cyagen Biosciences Inc. (Santa
Clara, CA, USA). MSCs were re-suspended at 37 °C, 5 %
CO2 in low-glucose Dulbecco’s modified Eagle’s medium
(Gibco, New York, NY, USA) containing 10 % fetal bovine
serum (Gibco) and 100 μg/ml penicillin and streptomycin
(Solarbio, Beijing, China). The medium was changed every
1 to 3 days. After two or three passages, MSCs were used
for transplantation to treat IBD. The immunophenotyping
of MSCs was analyzed by flow cytometry for CD44+ and
CD54+ antigen markers. When MSCs covered 80 % to 90 %
of the area of the culture bottle, they were passaged.
Transplantation was performed with passage 3 to passage
5 cells.
Experimental inflammatory bowel disease models
IBD experimental colitis rats model were induced by deliv-
ering 1.0 ml of 20 mg 2,4,6-trinitrobenzene sulfonic acid
(TNBS) (Sigma-Aldrich, St. Louis, MO, USA) in 50 % etha-
nol solution. A rubber infusion tube was positioned 8 cm
from the anus to instill TNBS into the lumen of the colon.
To ensure allocation of TNBS within the entire colon, rats
were maintained vertically for 1 minute. The normal group
received 0.1 ml of normal saline.
Green fluorescent protein-labeled mesenchymal stem cell
transplantation models
MSCs were transfected by virus to stable GFP fluores-
cence expression. Before MSCT models were established,
the concentration of MSCs was adjusted to 2×106/ml.
After 24-hour IBD model yielding, the rat tail was wiped
with a warm towel and alcohol for vein dilation. Then 1.0
ml of previous MSCs was transplanted via the tail vein.
Removal of colon tissue lesions from normal rats, IBD
rats, and MSCT rats was done at 14 and 28 days after
MSCT. Samples, which covered lesion region, were
removed from colon tissue 8 cm far from anus.
Histopathology
Four to six rats were killed on days 14 and 28 in the IBD
and MSCT groups. First, the colon tissues were observed
with the naked eye and with a microscope. Second, the
lesion tissues were fixed in 4 % buffered formaldehyde
and embedded in paraffin wax; histological samples were
Fig. 1 Photograph of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced
colitis at 14 days in a rat model
Table 1 Primers used in quantitative reverse transcription-polymerase chain reaction
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hematoxylin and eosin for light microscope and fluores-
cent microscope examination.
Genome-wide expression profile chip analysis
Total RNA was extracted from IBD colorectal tissues
and colorectal tissues at 28 days after MSCT and tran-
scribed into cDNA. The cDNA was scanned by the
Axon GenePix 400B microarray analysis scanner (Axon
Instruments, part of Molecular Devices, Sunnyvale, CA,
USA). Data were analyzed by NimbleScan version 2.6
software (NimbleGen, part of Roche, Basel, Switzerland)
(screening parameters are P <0.05 and fold change
(FC) >2). Mircoarray data are available at Gene Expression
Omnibus under accession number GSE68653.
RNA isolation and real-time polymerase chain reaction
Total RNA was extracted from MSCs, normal colorectal
tissues, IBD colorectal tissues, and colorectal tissues at
28 days after MSCT by using RNAiso Plus reagent in
accordance with the instructions of the manufacturer
(Takara, Otsu, Japan). The PrimeScript RT Master Mix
(Perfect Real Time) (Clontech, part of Takara) and 500 ng
of total RNA and poly-dT primers were used for synthesis
of cDNA. All gene-specific primers listed in Table 1 were
deposited in the Takara Corporation. Quantitative RT-
PCR was carried out by using SYBR Premix Ex Taq™
(Takara) and performed by using two-step amplification.
PCR amplification conditions were as follows: 95 °C for 30
seconds (one cycle), 95 °C for 3 seconds, and 60 °C for 30
seconds (40 cycles). The crossing threshold values were
obtained during the exponential amplification phase
by using the ABI 7500 Fast Real-Time PCR system
(Applied Biosystems, a brand of Thermo Fisher Scientific,
Waltham, MA, USA).Statistical analysis
Experiments were reproduced three times. In Table 1,
quantifiable determinations are expressed as mean ±
standard error of the mean of the indicated number of
experiments. Significance of differences was evaluated by
one-way analysis of variance, followed by the least sig-
nificant difference (LSD) test and Dunnett T3 test when
evaluating more than two conditions. Significant changes
are indicated as follows: *P <0.05, **P <0.01.Results
Macroscopic evaluation of TNBS-induced colitis in rat
Anatomic examination revealed pronounced colonic
damage, including bowel wall edema, luminal dilation,
mucosal erosions and ulcers, and even perforation
(Fig. 1). We also checked normal tissue from the same
Fig. 2 Characterization of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colonic epithelium damage and normal tissues at 14 days. a Normal
tissues under the microscope (hematoxylin and eosin (H&E), ×100). b Induced inflammatory bowel disease in rats (H&E, ×100)
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region (data not shown).
Histopathologic analysis of colonic epithelium in
inflammatory bowel disease rat model
Histochemical analysis of the colonic tissues revealed mu-
cosal lesions, edema, ulcers, and intense inflammatory cell
infiltrate in TNBS-induced colonic epithelium (Fig. 2). The
histological score was similar to our previously study and is
not shown here [12]. In the lamina propria, crypt and mu-
cosa caused serious inflammation, including diffusion of
granulocytes, leukocytes, and histiocytes; gland damage;
and goblet cell reduction or even disappearance. More
detailed results were described in our previous study [12].
Mesenchymal stem cells engraft in lesion tissues and
repair intestinal epithelium in an inflammatory bowel
disease rat model
The result of flow cytometry showed that MSCs expressed
CD44+ and CD54+ antigen markers. The positive cells of
CD44+ were 89.6±6.0 %, and those of CD54+ were 95.5±3.9 %
[12]. Well-grown MSCs with stable expression of GFP
were cultured (Fig. 3) and then transplanted into estab-
lished IBD rats. The pathological manifestations of IBD inFig. 3 The morphology of mesenchymal stem cells (MSCs) observed unde
expression of green fluorescent protein was observed in MSCs under fluorethe MSCT group were better than those in the IBD group;
most ulcers were healed, but edema and inflammatory cell
infiltration still existed (Fig. 4a). Under fluorescent micro-
scope, MSCs labeled by GFP were populated in the dam-
aged areas from the basement to the top of the fossae.
GFP-positive cell density accounted for more than 50 % of
the epithelial cells of the colorectal mucosa (Fig. 4b). In our
previous study, the Sry gene and Y chromosome were de-
tected by PCR and fluorescence in situ hybridization (FISH)
to determine the location of male donor cells in the female
colon after transplantation [12].
Genome-wide expression profile chips
At 14-day treatment with MSCT, main lesion colon tissues
were collected for chip analysis. Genome-wide expression
profile chips showed very good sample data trend and study
repeatability. When P <0.05 and FC >2 were screened for, a
total of 388 differentially expressive genes were found; of
these, 191 were upregulated and 197 downregulated in the
MSCT group in comparison with the IBD control group.
These genes were involved mainly in inflammatory
reaction, immune reaction, and cell differentiation. The top
10 and bottom 10 genes are shown in Tables 2 and 3,
respectively.r microscope. a Well-grown MSCs under microscope (×100). b Stable
scent microscope (×100)
Table 2 Top 10 expression genes analyzed by genome-wide expression profile chips in inflammatory bowel disease rats at 14 days
after treatment with mesenchymal stem cell transplantation
Gene ID Official symbol Official full name Fold changes
29266 Mcpt2 Mast cell protease 2 +21.28
29265 Mcpt1 Mast cell protease 1 +18.99
360922 Igj Immunoglobulin joining chain +17.38
56266 Cyp4f1 Cytochrome P450, family4, subfamily f, polypeptide 1 +17.98
24360 Fabp1 Fatty acid binding protein 1 +16.09
689116 Pigz Phosphatidylinositol glycan anchor biosynthesis, class z +15.87
290409 Olfm4 Olfactomedin 4 +14.46
286976 Gcnt3 Glucosaminyl (N-acetyl) transferase 3 +11.87
299354 Ighg Immunoglobulin heavy chain +11.34
36672 LOC366772 Similar immunoglobulin heavy chain +10.30
Table 3 Bottom 10 expression genes analyzed by genome-wide expression profile chips in inflammatory bowel disease rats at 14
days after treatment with mesenchymal stem cell transplantation
Gene ID Official symbol Official full name Fold changes
679314 LOC679314 Hypothetical protein LOC679314 −22.54
24249 S100g S100 calcium binding protein G −8.58
298873 Slc7a15 Solute carrier family 7, member 15 −6.99
81828 Zp2 Zona pellucida glycoprotein 2 −5.99
287644 Phospho1 Phosphatase, orphan 1 −5.88
155205 Slc36a1 Solute carrier family 36, member 1 −5.51
500973 Slc37a2 Solute carrier family 37, member 2 −4.62
361296 Rnf125 Ring finger protein 125 −4.46
308134 Tmem35 Transmembrane protein 35 −4.31
113902 Ces3 Carboxylesterase3 −4.15
In all 20 genes, atonal homolog 1 (Atoh1) and olfactomedin 4 (Olfm4) were upregulated and associated with the Notch signaling pathway. Wnt11 was
downregulated and related to the non-canonical Wnt signaling pathway. Other genes involved in the Wnt/β-catenin signaling pathway, such as Wnt3a, Wnt5a,
frizzled family receptor 3 (Fzd3), glycogen synthase kinase-3β (GSK-3β), β-catenin, myelocytomatosis oncogene (C-myc), cyclin D, T-cell factor 4 (Tcf4), and
adenomatous polyposis coli (APC), were also detected
Fig. 4 Observation of colon tissue at 28 days after mesenchymal stem cell transplantation (MSCT) under microscope and fluorescent microscope.
a Colon tissue lesion significantly improved after MSCT (hematoxylin and eosin, ×100). b The fluorescence signal could be observed in each layer
of intestinal tissue (×100)
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Table 4 Expression of Atoh1 and Olfm4 genes (χ±s)
Group Number Atoh1 Olfm4
MSCs 3 0.95±0.08 −0.46±0.24b,c
Normal 3 0.91±0.15 1.62±0.25a,c
IBD 9 0.99±0.48 2.54±0.20a,b
MSCT 9 1.34±0.27a-c 1.39±0.54a,c
aP <0.05 versus mesenchymal stem cell (MSC) group; bP <0.05 versus normal
group; cP <0.05 versus inflammatory bowel disease (IBD) group. MSCT,
mesenchymal stem cell transplantation
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transplantation repairing inflammatory bowel tissue
Atoh1 and olfactomedin 4 (Olfm4) were associated with the
Notch signaling pathway, which regulated cell proliferation
and differentiation [18, 19]. The expression of Atoh1 in the
MSCT group was significantly higher than in the MSC
(1.34±0.27 versus 0.95±0.08, P = 0.011), normal (1.34±0.27
versus 0.91±0.15, P = 0.004), or IBD rat models (1.34±0.27
versus 0.99±0.48, P = 0.007) (there were no significant dif-
ferences among these three groups). The expression ofTable 5 Expression of canonical pathway-related genes (χ±s)
Group Number Wnt3a Fzd3 GSK-3β A
MSCs 3 0.01±0.01b,c 0.12±0.01b,c 0.70±0.06b 0
Normal 6 1.00±0.01a,c 1.00±0.01a 1.00±0.01c 1
14-day IBD 3 2.44±0.63a,b 1.05±0.37a 0.62±0.04b 0
14-day MSCT 3 0.15±0.05a-c 0.35±0.07a-c 0.81±0.07c 0
28-day IBD 3 3.40±1.05a,b 1.34±0.15a 0.68±0.01b 1
28-day MSCT 3 0.14±0.02a-c 0.65±0.06a-c 0.78±0.11c 0
aP <0.05 versus mesenchymal stem cell (MSC) group; bP <0.05 versus normal group
stem cell transplantation
Fig. 5 Expression of atonal homolog 1 (Atoh1) and olfactomedin 4 (Olfm4)
treatment with mesenchymal stem cell transplantation (MSCT). a Expressio
groups. b Expression of Olfm4 increased in IBD group. MSC, mesenchymalOlfm4 in MSCT rats was downregulated in comparison
with IBD rats (P <0.05). No difference was found when
compared with normal rats (P >0.05) (Table 4, Fig. 5).
Canonical Wnt/β-catenin signaling pathway in
inflammatory bowel disease and mesenchymal stem cell
transplantation groups
Genes of the canonical pathway were verified by RT-PCR.
The expression of Wnt3a and β-catenin increased signifi-
cantly, and GSK-3β decreased in the IBD rat group, com-
pared with normal rats, at 14 and 28 days. Adenomatous
polyposis coli (APC) and cyclin D exhibited downregulated
expression in the IBD rat group at 14 days and demon-
strated upregulation at 28 days compared with the normal
group. There were no differences in the expression of Fzd3,
TCF4, and c-myc between IBD model rats and the normal
group (Table 5, Fig. 6).
The gene expressions in MSCT rats are shown in
Fig. 6. The expression of Wnt3a, Fzd3, TCF4, and cyclin
D significantly declined after MSCT, compared with thePC β-catenin TCF4 C-myc Cyclin D
.36±0.01b,c 0.65±0.17c 0.35±0.01b,c 2.60±0.17b 2.39±0.13b,c
.00±0.01a 1.00±0.01c 1.00±0.01a 1.00±0.01a 1.00±0.01a
.63±0.04a,b 1.58±0.32a,b 1.16±0.30a 1.64±0.32 0.61±0.24a,b
.53±0.07b 1.37±0.34a 0.71±0.09a-c 2.00±0.01b 0.72±0.07a
.05±0.01a 1.93±0.55a,b 1.12±0.22a 1.20±0.58 1.40±0.10a
.96±0.13 0.82±0.17c 0.76±0.14a-c 0.31±0.10a-c 0.18±0.07a-c
; cP <0.05 versus inflammatory bowel disease (IBD) group. MSCT, mesenchymal
genes in inflammatory bowel disease (IBD) rats at 14 days after
n of Atoh1 in MSCT group upregulated in comparison with the other
stem cell. *P<0.05
Fig. 6 Expression of canonical Wnt signaling-related genes in mesenchymal stem cell transplantation (MSCT) group compared with inflammatory bowel
disease (IBD) rat model. a Wnt3a mRNA decreased expression in MSCT rats compared with IBD rats (P = 0.004). b Declined Fzd3 expression (P = 0.014).
c Decreased GSK-3β mRNA expression in inflammation (P = 0.035) and recovery to normal level after MSCT. d Decreased expression of APC at 14 days
(P = 0.034), increased to normal level at 28 days. e Lower β-catenin mRNA expression in MSCT rats (P <0.001). f No different expression of TCF4 between
IBD group and normal group, and low expression in mesenchymal stem cells (MSCs) (P = 0.036). g High c-myc expression at 14 days (P <0.01) declined at
28 days (P = 0.024). h Reduced cyclin D expression in MSCT at 28 days (P = 0.02)
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Table 6 Expression of Wnt5a and Wnt11 genes (χ±s)
Group Number Wnt5a Wnt11
MSCs 3 2.03±0.64 0.01±0.003b
Normal 6 1.00±0.01 1.00±0.01a,c
14-day IBD 3 1.17±0.09 0.51±0.06a,b
14-day MSCT 3 1.18±0.06 0.10±0.02b
28-day IBD 3 1.48±0.47 1.07±0.39a,c
28-day MSCT 3 0.69±0.04a-c 0.22±0.07b
aP <0.05 versus mesenchymal stem cell (MSC) group; bP <0.05 versus normal
group; cP <0.05 versus inflammatory bowel disease (IBD) rat model. MSCT,
mesenchymal stem cell transplantation
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3β was upregulated to normal levels and was higher than
in IBD rat models. In the MSCT group, β-catenin ex-
pression was lower than that of the IBD rat group at 28
days. APC expression did not change in the MSCT
group. C-myc exhibited increased expression at 14 days
and decreased expression at 28 days, compared with the
IBD group, whereas c-myc and cyclin D showed high ex-
pression, and other genes demonstrated comparatively
lower expression in MSCs.
Non-canonical Wnt signaling pathway in inflammatory
bowel disease and mesenchymal stem cell
transplantation groups
Wnt5a and Wnt11, two main genes in the non-canonical
Wnt signaling pathway, were screened with RT-PCR.
Wnt5a did not change significantly at 14 days and showed
lower expression at 28 days in the MSCT group (P = 0.04).
Wnt11 showed lower expression in the MSCT group com-
pared with the IBD group at 14 and 28 days (P = 0.048); in
the IBD model, Wnt11 decreased at 14 days (P = 0.019)Fig. 7 Expression of non-canonical Wnt signaling genes in mesenchymal stem c
(IBD) rat model. a Declined Wnt5a mRNA expression on day 28 in the MSCT grouand was restored to normal level at 28 days (P >0.05)
(Table 6, Fig. 7).
Discussion
The intestinal stem cells showed renewal, proliferation, and
differentiation capacity and were able to restore the intes-
tinal mucosa [11]. Transplanted MSCs demonstrated the
ability to engraft into the intestinal mucosa [12, 20] and al-
leviate the autoimmune response, facilitating the treatment
of IBD [21]. Previous studies demonstrated that MSCs
could engraft into the damaged area of intestinal epithelium
tissues, showing characteristics of epithelial cells [22, 23].
Intestinal stem cells have several signaling pathways,
such as Wnt, BMP, PI3K/Akt, Hedgehog, and Notch path-
ways. Wnt and Notch signaling pathways play important
roles in determining intestinal stem cell fate, including
maintenance of stem cell homeostasis, inhibition of cell
differentiation, and control of Paneth cell development
[24]. Meanwhile, those pathways are also crucial in MSCs,
which regulate self-renewal and differentiation [25]. Ca-
nonical Wnt signaling activated by Wnt3a enhances the
proliferation of MSCs and suppresses MSC osteogenic dif-
ferentiation, whereas non-canonical Wnt signaling acti-
vated by Wnt5a maintains MSC numbers and promotes
osteogenesis [26]. The Notch pathway also regulates MSC
fate and osteoblastic differentiation [27]. In recent years,
Wnt3a and Fzd3 were reported to increase expression in
IBD colon tissues compared with non-IBD colon tissues
[28]. The protein level of β-catenin was found to increase
in colonic epithelial crypts from damaged mucosa [29].
In our study, we successfully established the IBD and
MSCT model rats and then found that MSCs labeled with
green fluorescence were populated in the damaged areas
after MSCT. In our previous study, we have demonstratedell transplantation (MSCT) group compared with inflammatory bowel disease
p. b Lower expression of Wnt11 in MSCT rats. MSC, mesenchymal stem cell
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in the ulcerated experimental colitis region of a rat model
after transplantation; male donor cells were followed by Sry
gene using PCR and Y chromosome FISH in female recipi-
ents, and the donor cell rate was evaluated by brown
positive cells labeled by bromodeoxyuridine (BrdU)
immunohistochemistry. MSCs not only were engrafted in
the damaged areas but also were the major source for intes-
tinal epithelia renewal [12]. The other research also proved
that MSCs transplanted into gastric tissue, and the benefi-
cial effects might be mediated by MSCs differentiated into
gastric interstitial cells [30]. In this study, the fluorescence
signal cell was observed in all views of each layer of intes-
tinal tissue, and the vast majority of cells in the intestinal le-
sion tissue were derived from GFP-labeled MSCs. When
intestinal epithelium was inflamed, we found that canonical
Wnt signaling was activated by Wnt3a and inhibited by
GSK-3β and APC, and the transcription of downstream-
related factors would be regulated. These changes pro-
moted intestinal stem cell proliferation and repaired the in-
testinal mucosa. On the other hand, the expression of Fzd3,
c-myc, and cyclin D did not change significantly in IBD rats.
These results suggest that Wnt3a and Fzd3 may not work
together in activating canonical Wnt signaling to accelerate
intestinal stem cell proliferation by promoting the tran-
scription of c-myc and cyclin D. After MSCT, canonical
Wnt signaling-related genes such asWnt3a, Fzd3, β-catenin,
TCF4, and cyclin D exhibited downregulation, and GSK-3β
exhibited upregulation, compared with IBD rats; the canon-
ical Wnt signaling pathway may be inhibited when treated
with MSCs.
The expression of APC differed from that of c-myc. APC
declined on day 14 and increased to normal levels on day
28 in IBD rats after MSCT. The expression of c-myc was
increased on day 14 and decreased on day 28 in the MSCT
group. C-myc was reportedly the target gene of the APC
pathway [31] and showed high expression in MSCs. Pre-
sumably, MSCT might accelerate the expression of c-myc
in the early stage, inhibiting APC expression, and promot-
ing the proliferation of the MSC itself. On day 28, the de-
creased expression of c-myc promoted the differentiation of
MSCs into intestinal stem cells.
In the non-canonical Wnt signaling pathway, Wnt11 can
either activate or inhibit the canonical pathway [32, 33]. In
our research, expression of Wnt11 decreased on day 14 and
increased to normal levels on day 28. But the expression of
Wnt5a did not differ between the IBD group and the nor-
mal group. In IBD rats treated with MSCT, both Wnt5a
and Wnt11 expressions were lower than in IBD and normal
rats. We speculated that the non-canonical Wnt signaling
activated by Wnt11 may have been inhibited by canonical
signaling in IBD, but the non-canonical Wnt signaling acti-
vated byWnt5a did not change in inflammatory conditions.
Regardless of which signaling molecule activated the non-canonical signaling pathway, both may be inhibited after
MSCT.
Olfm4 was the target gene of Notch signaling and partici-
pated in stem cell fate. The expression of Olfm4 in the in-
testine rapidly decreased after Notch inhibition, and
increased Olfm4 expression was observed after activation of
Notch signaling [34]. In the present study, the expression of
Olfm4 significantly increased in IBD rats compared with
normal rats and MSCT rats. This increased expression in
IBD is consistent with the conclusions of Gersemann et al.
[35]. Atoh1 was an inhibitor of the Notch signaling pathway
and essential to the differentiation of intestinal stem cells
[36]. After MSCT, expression of Olfm4 was downregulated
and Atoh1 was upregulated. This suggests that Notch
signaling may be suppressed in the process of MSCT
treatment.Conclusions
In this study, we investigated the effect of Wnt and Notch
signaling in the process of MSCT repair of inflammatory
bowel disease in a rat model. Our results suggest that
canonical Wnt and Notch signaling pathways are activated
to promote the proliferation of intestinal stem cells in IBD,
countering inflammation. Non-canonical Wnt signaling may
be suppressed by canonical signaling during inflammation.
In treatment with MSCs, Notch and Wnt signaling path-
ways are inhibited to prevent stem cell proliferation and
promote MSC differentiation to intestinal epithelial cells.
Shortly after MSCT, the high expression of c-myc and low
expression of APC mRNA facilitate MSC proliferation, and
then differentiation into intestinal epithelial cells in the ana-
phase, by reducing the expression of c-myc.Abbreviations
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